
WELL · NYSE
Consensus is Buy across 19 analysts. The supplied consensus snapshot puts the low, mean and high price targets all at $260, so it reports no target dispersion; that differs from Barclays' separately reported $246 target after its Oct. 13 reduction. The only explicit weekly target revision is Barclays', with analyst Richard Hightower maintaining Equal-Weight; the evidence does not identify other changes or a net revision direction across the full analyst set. The snapshot does not name the most- or least-bullish analysts, and identical low, mean and high targets prevent a meaningful ranking of target spread. The substantive disagreement visible here is valuation: Simply Wall St flags a premium after a 221% run, while coverage highlights stronger senior-housing occupancy and NOI.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Barclays | Richard Hightower | $246 | +2.0% | Oct 13, 2026 | Open the report this row came from | |
| JPMorgan | — | $260 | +7.8% | Sep 24, 2026 |
| Evercore ISI | — | $256 | +6.1% | Sep 21, 2026 | Open the report this row came from |
| Citigroup Inc. | — | $255 | +5.7% | May 5, 2026 | Open the report this row came from |
| BMO Capital Markets | — | $245 | +1.6% | May 4, 2026 | Open the report this row came from |
| Citigroup Inc. | — | $275 | +14.0% | May 4, 2026 | Open the report this row came from |